Apoptosis: A programmed cell death involved in ovarian and uterine physiology

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 67, Issue 2, 1996, Pages 85-102

  Vinatier, D ^a   Dufour, Ph ^a   Subtil, D ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Apoptosis; Homeostasis; Ovary; Uterus

Indexed keywords

APOPTOSIS; CELL COMMUNICATION; CELL DEATH; ENDOMETRIUM; FEMALE; HUMAN; INFLAMMATION; OVARY; PRIORITY JOURNAL; REVIEW; UTERUS;

EID: 0030217985     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(96)02467-0     Document Type: Review

References (282)

1. [1] Wyllie AH. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metast Rev 1992; 11: 95-103.
2. [2] Kerr JF, Willie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
3. [3] Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555-556.
4. [4] Schwartzman RA, Cidlowski A. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrine Rev 1993; 14: 133-150.
5. [5] Wyllie AH, Kerr JFR, Macaskill IAM, Currie AR. Adrenocortical cell deletion: the role of ACTH. J Pathol 1973; 111: 85-94.
6. [6] Arends MJ, Wyllie AH. Apoptosis: mechanisms and roles in pathology. Int Rev Exp Pathol 1991; 32: 223-254.
7. [7] Duke RC, Chervenak R, Cohen JJ. Endogenous endonuclease induced DNA fragmentation: an early event in cell-mediated cytolysis. Proc Natl Acad Sci USA 1983; 80: 6361-6365.
8. [8] Kyprianou N, Isaacs JT. Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 1988; 122: 552-562.
9. [9] McConkey DJ, Aguilar-Santelises M et al. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J Immunol 1991; 146: 1072-1076.
10. [10] Rotello RJ, Hocker MB, Gerschenson LE. Biochemical evidence for programmed cell death in rabbit uterine epithelium. Am J Pathol 1989; 134: 491-495.
11. [11] Yanaghihara K, Tsumuraya M. Transforming growth factor β1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 1992; 52: 4042-4045.
12. [12] Cohen GM, Sun X-M, Snowden RT, Dinsdale D, Skilleter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 1992; 286: 331-334.
13. [13] Collins RJ, Harmon BV, Gobe GC, Kerr JFR. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol 1992; 61: 451-453.
14. [14] Ucker DS, Obermiller PS, Eckart W, Apgar JR, Berger NA, Meyers J. genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T Lymphocytes. Mol Cell Biol 1992; 12: 3060-3069.
15. [15] Brown DG, Sun XM, Cohen GM. Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem 1993; 268: 3037-3039.
16. [16] Zhivotovsky B, Wade D, Gahm A, Orrenius S, Nicotera. Formation of 50 kbp chromatin fragments in isolated liver nuclei is mediated by protease and endonuclease activation. FEBS Lett 1994; 351: 150-154.
17. [17] Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependant endonuclease in thymocyte nuclei leads to cell death. J Immunol 1984; 132: 38-42.
18. [18] Mannherz HG, Peitsch MC, Zanotti S, Paddenberg R, Polzar B. A new function for an old enzyme: the role of DNase I in apoptosis. Curr Top Microbiol Immunol 1995; 198: 161-174.
19. [19] Peitsch MC, Mannherz HG, Tschopp J. The apoptosis endonucleases: cleanig up after cell death ?. Trend Cell Biol 1994; 4: 37-41.
20. [20] Barry MA, Behnke CA, Eastman A. Activation of programmed cell death apoptosis by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharm 1990; 40: 2353-2362.
21. [21] Gaido ML, Cidlowski JA. Identification, purification, and characterization of a calcium-dependant endonuclease NUC 18 from apoptotic rat thymocytes. J Biol Chem 1991; 266: 18580-18585.
22. [22] Peitsch MC, Polzar B, Stephan H et al. Characterization of the endognenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis programmed cell death. EMBO J 1993; 12: 371-377.
23. [23] Vanderbilt JN, Bloom KS, Andersonn JN. Endogenous nuclease: properties and effects of transcribed genes in chromatin. J Biol Chem 1982; 257: 13009-13017.
24. [24] Allbritton NL, Verret CR, Wolley RC, Eisen HN. Calcium ion concentrations and DNA fragmentation in target cell destruction by murine cloned cytotoxic T lymphocytes. J Exp Med 1988; 167: 514-527.
25. [25] Jones PBC, Welsch Jr TH, Hsueh AJW. Regulation of ovarian progestin production by epidermal growth factor in cultured rat granulosa cells. J Biol Chem 1982; 257: 11268-11273.
26. [26] McConkey DJ, Hartzell P, Nicotera P, Orrenius S. Stimulation of endogenous endonuclease in cells exposed to oxydative stress. Toxicol Lett 1989; 42: 123-130.
27. [27] McConkey DJ, Hartzell P, Chow SC, Orrenius S, Jondal M. Interleukin 1 inhibits T cell receptor-mediated apopotosis in immature thymocytes. J Biol Chem 1990; 265: 3009-3011.
28. [28] Kaiser N, Edelman IS. Calcium dependance of glucocorticoid induced lymphocytolysis. Proc Natl Acad Sci USA 1977; 74: 638-642.
29. [29] Lee S, Christaros S, Small MB. Apoptosis and signal transduction: clues to a molecular mechanism. Curr Opin Cell Biol 1993; 5: 286-291.
30. [30] Mc Gabe MJ, Nicotera P, Orenius S. Calcium-dependant cell death. Role of the endonuclease, protein kinase C, and chromatin conformation. Ann NY Acad Sci 1992; 663: 269-278.
31. [31] Martikainen P, Isaacs J. Role of calcium in the programmed cell death of rat ventral prostatic glandular cells. Prostate 1990; 17: 175-187.
32. [32] Juntti-berggren L, Larsson O, Rorsman P, Ammala C, Bokvist K, Wahlander K et al. Increased activity of L-type Ca2+ channels exposed to serum from patients with type 1 diabetes. Science 1993; 261: 86-90.
33. [33] Almenri ES, Litwack G. Activation of internucleosomal DNA cleavage in human CEM lymphocytes by glucocorticoid and novobiocin. J Biol Chem 1990; 265: 17323-17333.
34. [34] Bansal N, Houle AG, Melnykovych G. Dexamethasone-induced killing of neoplastic cells of lymphoid derivation: lack of early calcium involvement. J Cell Physiol 1990; 143: 105-109.
35. [35] Lennon SV, Kilfeather SA, Hallen MB, Campbell AK, Cotter TG. Elevation in cytosolic free Ca2+ are not required to trigger apoptosis in human leukemia cells. Clin Exp Immunol 1992; 87: 465-471.
36. [36] Rodrigez-tarduchy G, Malde P, Lopez-rivas A, Collins MKL. Inhibition of apoptosis by calcium ionophores in IL-3 dependant bone marrow cells is dependent upon production of IL-4. J Immunol 1992; 148: 1416-1422.
37. [37] Bacskai BJ, Friedman PA. Activation of latent Ca2+ channels in renal epithelial cells by parathyroid hormone. Nature 1990; 347: 388-391.
38. [38] Nicotera P, Zhivotovsky B, Orrenius S. Nuclear calcium transport and the role of calcium in apoptosis. Cell Calcium 1994; 16: 279-288.
39. [39] Brune B, Hartzell P, Nicotera P, Orrenius S. Spermine prevents endonuclease activation and apoptosis in thymocytes. Exp Cell Res 1991; 195: 323-329.
40. [40] Snyder R. Polyamine depletion is associated with altered chromatin structure in HeLa cells. Biochem J 1989; 261: 697-704.
41. [41] Orrenius S. Apoptosis: molecular mechanisms and implications for human disease. J Intern Med 1995; 237: 529-536.
42. [42] Chow SC, Weiss M, Kass GE, Holmstrom TH, Eriksson JE, Orrenius S. involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes. FEBS Lett 1995; 364: 134-138.
43. [43] Schelgel J, Peters I, Orrenius S. Isolation and partial characterization of a protease involved in Fas-induced apoptosis. FEBS Lett 1995; 364: 139-142.
44. [44] Gorczyca W, Bruno S, Darzynkiewicz RJ, Gong J, Darzynkeiwicz Z. dna strand breaks occuring during apoptosis: their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol 1992; 1: 639-648.
45. [45] Wyllie AH, Morris RG. Hormone-induced cell death: purification and properties of thymocytes undergoing apoptosis after glucocorticoid treatment. Am J Pathol 1982; 109: 78-87.
46. [46] Cotter TG, Glynn JM, Echeverri F, Green DR. The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle. Anticancer Res 1992; 12: 773-780.
47. [47] Fesus L, Davies PJA, Piacentini M. Apotosis: molecular mechanisms in programmed cell death. Eur J Cell Biol 1991; 56: 170-177.
48. [48] Tenniswood MP, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh J-E. active cell death in hormone-dependant tissues. Canc Metastasis Rev 1992; 11: 197-220.
49. [49] Fesus L, Thomazy V. Searching for the function of tissue transglutaminase: its possible involvement in the biochemical pathway of programmed cell death. Adv Exp Med Biol 1988; 231: 119-134.
50. [50] Piacentini M, Fesus L, Farrace MG, Ghibelli L, Piredda L, Melino G. the expression of tissue transglutaminase in two human cancer cell lines is related with programmed cell death apoptosis. Eur J Cell Biol 1991; 54: 246-254.
51. [51] Jacobson MD, Burne JF, Raff MC. Programmed cell death and bcl-2 protection in the absence of a nucleus. EMBO J 1994; 13: 1899-1910.
52. [52] Nalim CM. Apoptosis research enters the ICE age. Structure 1995; 3: 143-146.
53. [53] Wang L, Miura M, Bergeron L, Zhu H, Yuan J. An ICE/ced-3 related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78: 739-750.
54. [54] Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995; 375: 78-81.
55. [55] Krammer PH, Foers W, Schulze-osthoff K. Requirement of an ICE/CED-3 protease for Fas/APO1-1 mediated apoptosis. Nature 1995; 375: 81-83.
56. [56] Wright SC, Wei QS, Zhong J, Zheng H, Kinder DH, Larrick JW. Purification of a 24-kD protease from apoptotic tumor cells that activates DNA fragmentation. J Exp Med 1994; 180: 2113-2123.
57. [57] Greenberg AH, Litchfield DW. Granzymes and apoptosis: targeting the cell cycle. Curr Top Microbiol Immunol 1995; 198: 95-119.
58. [58] Fernandez-alnemri T, Litwack G, Alnemri ES. CPP32, a novel human protein with homology to Caenorhabditis elegans cell death protein ced-3 and mammalian interleukin-1b-converting enzyme. J Biol Chem 1994; 269: 30761-30764.
59. [59] Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP et al. Identification and inhibition of the iCE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 386: 37-43.
60. [60] Faucheu C, Diu A, Chan AW et al. A novel human protein similar to the interleukin-1 beta converting enzymz induces apoptosis in transfected cells. EMBO J 1995; 14: 1914-1922.
61. [61] Casciola-rosen LA, Miller DK, Anhalt GJ, Rosen A. Specific cleavage of the 70-kDa protein component of the Ul small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994; 269: 30757-30760.
62. [62] Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. cleavage of polyADP-ribose polymerase by a proteinase with properties like iCE. Nature 1994; 371: 346-347.
63. [63] Tewari M, Quan LT, O Rourke K et al. Yama/CPP32b, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate polyADP-ribose polymerase. Cell 1995; 81: 801-809.
64. [64] Newmeyer DD, Farschon DM, Reed JC. Cell-free apoptosis in xenopus egg extracts: inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 1994; 79: 353-364.
65. [65] Zamzami N, Marchetti P, Castedo M et al. Sequential reduction of mitochondrial transmembrane potential and genration of reactive oxygen species in early programmed cell death. J Exp Med 1995; 182: 367-377.
66. [66] Kroemer G, Peit P, Zamzami N, Vayssiere JL, Mignotte B. The biochemistry of programmed cell death. FASEB J 1995; 9: 1277-1287.
67. [67] Jacobson MD, Raff MC. Programmed cell death and bcl-2 protection in very low oxygen. Nature 1995; 374: 814-816.
68. [68] Falciera E, Gobbi P, Cataldi A, Zamai L, Faenza I, Vitale M. Nuclear pore in the apoptotic cell. Histochem J 1994; 26: 754-763.
69. [69] Savill J, Fadok V, Henson A, Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 1993; 14: 131-136.
70. [70] Duvall E, Wyllie AH, Morris RG. Macrophage recognition of cells undergoing programmed cell death apoptosis. Immunology 1985; 56: 351-358.
71. [71] Ren Y, Silverstein RL, Allen J, Savill J. CD36 gene transfert confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995; 181: 1857-1862.
72. [72] Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. exposure of phosphatidyl serine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages . J Immunol 1992; 148: 2207-2216.
73. [73] Martin SJ, Reutelingsperger CPM, McGahon AJ et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of bcl- and Abl. J Exp Med 1995; 182: 1545-1556.
74. [74] Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidyl serine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995; 182: 1597-1601.
75. [75] Dranfield I, Stocks SC, Haslett C. Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood 1995; 85: 3264-3273.
76. [76] Barr PJ, Tomei LD. Apoptosis and its role in human disease. Biotechnology 1994; 12: 487-493.
77. [77] Kerr JFR, Winterford CM. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-2026.
78. [78] Prindull G. Apoptosis in the embryo and tumorigenesis. Eur J Canc 1995; 31A: 116-123.
79. [79] Cohen JJ. Apoptosis: Physiologic cell death. J Lab Clin Med 1994; 124: 761-765.
80. [80] Garcia-Martinez V, Macias D, Schmied M et al. Internucleosomal DNA fragmentation and programmed cell death apoptosis in the interdigital tissue of the embryonic chick leg bud. J Cell Sci 1993; 106: 201-208.
81. [81] Koseki C, Herzlinger D, AL-Awqati Q. Apoptosis in metanephric development. J Cell Biol 1992; 119: 1327-1333.
82. [82] Hikim AP, Wang C, Leung A, Swerdloff RS. Involvement of apoptosis in the induction of germ cell degeneration in adult rats after gonadotropin-releasing hormone antagonist treatment. Endocrinology 1995; 136: 2770-2775.
83. [83] James TN. Normal and abnormal consequences of apotosis in the human heart. From post natal morphogenesis to paroxysmal arrhythmias. Circulation 1994; 90: 556-571.
84. [84] Sanvito F, Herrera PL, Huarte J, Nichols A, Montesano R, Orci L, Vassali JD. TGF-beta influences the relative development of the exocrine and endocrine pancreas in vitro. Development 1994; 120: 3451-3462.
85. [85] Coucouvanis EC, Sherwood SW, Carswell-Crumpton, Spark EG, Jones PP. evidence that the mechanism of prenatal cell death in the mous is apoptosis. Exp Cell Res 1993; 209: 238-247.
86. [86] Mitrovic D. Régression des fentes articulaires normalement constituées chez l' embryon de poulet paralysé. C R Acad Sci III 1972; 274: 288-291.
87. [87] Mori C, Nakamura N, Kimura S, Irie H, Takigawa T, Shiota K. Programmed cell death in the interdigital tissue of the fetal mouse limb is apoptosis with DNA fragmentation. Anat Rec 1995; 242: 103-110.
88. [88] Clarke PGH. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 1990; 181: 195-213.
89. [89] Dickson DW. Apoptosis in the brain. Am J Pathol 1995; 146: 1121-1130.
90. [90] Raff MC, Barres BA, Burne JF, Coles HS, Ishizaki Y, Jacobson MD. programmed cell death and control of cell survival: lessons from the nervous system. Science 1993; 262: 695-700.
91. [91] Najbauer J, Leon B. Olfactory experience modulated apoptosis in the developing olfactory bulb. Brain Res 1995; 674:245-251.
92. [92] Brown GD, Hulme C, Hyland PD, Mitchell IJ. Cell suicide in the developing nervous system: a functional neural network model. Brain Res Cogn Brain Res 1994; 2: 71-75.
93. [93] Gordon N. Apoptosis programmed cell death and other reasons for eliminating of neurons ans axons. Brain Dev 1995; 17: 73-77.
94. [94] King LB, Ashwell JD. Signalling for death of lymphoid cells. Curr Opin Immunol 1993; 5: 368-373.
95. [95] Benedetti, Jezequel AM, Orlandi F. Preferential distribution of apoptotic bodies in acinar zone 3 of the normal human and rat liver. J Hepatol 1988; 7: 319-324.
96. [96] Kerr JFR. Shrinkage necrosis: a distinct mode of cellular death. J Pathol 1971; 105: 13-20.
97. [97] Sterle M, Pipan N. Analysis of the cell death in the mucoid epithelium of mouse stomach. Folia Histochem Cytobiol 1994; 32: 155-160.
98. [98] Potten CS. Extreme sensibility of some intestinal crypt cells to X and γ irradiation. Nature 1977; 269: 518-521.
99. [99] Raff MC. Social control on cell suvival and cell death. Nature 1992; 356: 397-400.
100. [100] Walker NI, Bennett RE, Kerr JFR. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am J Anat 1989; 185: 19-32.
101. [101] O Shea JD, Hay MF, Cran DG. Ultrastructural changes in the theca interna during follicular atresia in sheep. J Reprod Fertil 1978; 54: 183-187.
102. [102] Desmouliere A, Redard M, Darby I, Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995; 146: 56-66.
103. [103] Korsmeyer SJ. Regulators of cell death. Trends Genet 1995; 11: 101-105.
104. [104] Potten CS, Merritt A, Hickman J, Hall P, Faranda A. Characterization of radiation-induced apoptosis in the small intestine and its biological implications. Int J Radiat Biol 1994; 65: 71-78.
105. [105] Sellins KS, Cohen JJ. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987; 139: 3199-3206.
106. [106] Yanagihara NII M, Numoto M, Kamita K, Tauchi H, Sawada S, Seito T. radiatio-induced apoptotic cell death in human gastric epithelial tumour cells: correlation between mitotic death and apoptosis. Int J Radiat Biol 1995; 67: 677-685.
107. [107] Takano YS, Harmon BV, Kerr JFR. Apoptosis induced by mild hyperthermia and murine tumour cell lines: a study using electron microscopy and DNA gel electrophoresis. J Pathol 1991; 163: 329-336.
108. [108] Bazar LS, Deeg HJ. Ultraviolet B-induced DNA fragmentation apoptosis in activated T-lymphocytes and Jurkatt cells is augmented by inhibition of RNA and protein synthesis. Exp Hematol 1992; 20: 80-86.
109. [109] Martin SJ, Cotter TG. Ultraviolet B irradiation of human leukemia HL-60 cells in vitro induces apoptosis. Int J Radiat Biol 1991; 59: 1001-1016.
110. [110] Dubrez L, Goldwasser F, Genne P, Pommier Y, Solary E. The role of cell cycle regulation and apoptosis triggering in determining ythe sensibility of leukemic cells to topoisomerase I and II inhibitors. Leukemia 1995; 9: 1013-1024.
111. [111] Mizumoto K, Rothman RJ, Farber JL. Programmed cell death apoptosis of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide. Mol Pharmacol 1994; 46: 890-895.
112. [112] Revoltella RP, Borney F, Dal-Canto B, Durso CM. Apoptosis of serum-free C2.8 mouse embryo hepatocytic cells caused by hepatocyte growth factor deprivation. Cytotechnology 1993; 13: 13-19.
113. [113] Otani H, Erdos M, Leonard WJ. Tyrosine kinases regulate apoptosi and bcl-2 expression in a growth factor-dependant cell line. J Biol Chem 1993; 268: 22733-22736.
114. [114] Rebollo A, Gomez J, Martinez-De-Aragon A, Lastres P, Silva A, Perez-Sala D. Apoptosis induced by IL-2 withdrawal is associated with an intracellular acidification. Exp Cell Res 1995; 218: 581-585.
115. [115] Rodrigez-Tarduchy G, Collins M, Lopez Rivas A. Regulation of apoptosis in interleukin-3 dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J 1990; 9: 2997-3002.
116. [116] Kawano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A. differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 1995; 85: 487-494.
117. [117] Schwarze MM, Hawley RG. Prevention of myeloma cell apoptosis by ectopic bcl-2 expression or interleukin 6 mediated up-regulation of bcl-xL. Cancer Res 1995; 55: 2262-2265.
118. [118] Williams GT, Smith CA, Spooner E, Dexter TM, Taylor DR. Haematopoietic colony stimulating dfactors promote cell survival by suppressing apoptosis. Nature 1990; 343: 76-79.
119. [119] Grell M, Zimmermann G, Husler D, Pfizenmaier K, Scheurich P. TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J Immunol 1994; 153: 1963-1972.
120. [120] Higuchi M, Aggarwal BB. P80 form of the human tumor necrosis factor receptor is involved in DNA fragmentation. FEBS Lett 1993; 331: 252-255.
121. [121] Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995; 81: 465-504.
122. [122] Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J Immunol 1998; 141: 2629-2634.
123. [123] Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 1995; 146: 1220-1234.
124. [124] Mangan DF, Wahl SM. Differential regulation of human monocyte programmed cell death apoptosis by chemotactic factors and pro-inflammatory cytokines. J Immunol 1991; 147: 3408-3412.
125. [125] Obeid LM, Linardic CM, Karolak LA, Hannus YA. Programmed cell death induced by ceramide. Science 1993; 259: 1769-1771.
126. [126] Zhang W, Naomoto Y, Tanaka N, Hizuta A, Orita K. Synergistic effect of tumor necrosis factor-a and Interferon γ on the induction of apoptosis detected by BM-1/JIMRO: a new marker of apoptosis. Acta Med Okayama 1994; 48: 51-55.
127. [127] Shinagawa T, Yoshioka K, Kakumu S et al. Apoptosis in cultured rat hepatocytes: the effects of tumour necrosis factor α and interferon γ. J Pathol 1991; 165: 247-253.
128. [128] Voeklel-Johnson C, Entingh AJ, Wold WS, Gooding LR, Laster SM. activation of intracellular proteases is an early event in TNF-induced apoptosis. J Immunol 1995; 154: 1707-1716.
129. [129] Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996; 12: 1-9.
130. [130] Manabe A, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Pui CH, Campana D. Interleukin-4 induces programmed cell death apoptosis in cases of high-risk acute lymphoblastic leukemia. Blood 1994; 83: 1731-1737.
131. [131] Alan R, Forsythe P, Stafford S, Fukuda Y. Tranforming growth factor β abrogates the effects of hematopoietins on eosinophils and induces their apoptosis. J Exp Med 1994; 179: 1041-1045.
132. [132] Lin JK, Chou CK. In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor β1. Cancer Res 1992; 52: 385-388.
133. [133] Lomo J, Blomhoff HK, Beiske K, Stokke T, Smeland EB. TGF-beta 1 and cyclic AMP promote apoptosis in resting human B lymphocytes. J Immunol 1995; 154: 1634-1643.
134. [134] Martikainen P, Kyprianou N, Isaacs JT. Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells. Endocrinology 1990; 127: 2963-2968.
135. [135] Moulton BC. Transforming growth factor -β stimulates endometrial stromal apoptosis. Endocrinology 1994; 134: 1055-1060.
136. [136] Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W, Schult. induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 1992; 89: 5408-5412.
137. [137] Rotello RJ, Lieberman RC, Purchio AF, Gerschenson LE. Coordinated reulation of apoptosis and cell proliferation by transforming growth factor b1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA 1991; 88: 3412-3415.
138. [138] Neta R, Douches S, Oppenheim JJ. Interleukin 1 is a radioprotector. J Immunol 1986; 2483-2485.
139. [139] Cunnigham jrET, De Souza EB. Interleukin 1 receptorsin the brain and endocrine tissues. Immunol Today 1993; 14: 171-176.
140. [140] Ankarcrona M, Dypbukt JM, Brune B, Nicotera P. Intrleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 1994; 213: 172-177.
141. [141] Bergmann L, Kroncke -D, Suschek C, Kolb H, Kolb-Bachofern V. Cytotoxic action of IL-1 β against pancreatic islets is mediated via nitric oide formation and is inhibited by Ng-monomethyl-L-arginine. FEBS lett 1992; 299: 102-106.
142. [142] Hogquist KA, Nett MA, Unamue ER. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 1991; 88: 8485-8489.
143. [143] Berges R, Furuya Y, Remington L, English HF, Jacks T, Isaacs JT. cell proliferation, DNA repair, and p53 function are not required for programmed cell death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 1993; 90: 8910-8914.
144. [144] Martin L, Finn CA. Interactions of oestradiol and progestins in the mouse uterus. J Endocrinol 1970; 48: 109-115.
145. [145] Kyprianou N, English HF, Davidson NE, Issacs JT. Programmed cells death during regression of the MCF-7 human breast cancer fllowing estrogen ablation. Cancer Res 1991; 51: 162-166.
146. [146] Rotello RJ, Lieberman RC, Lepoff RB, Gerschenson LE. Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU 486. Am J Pathol 1992; 140: 449-456.
147. [147] Martin SJ, Lennon SV, Bonham AM, Cotter TG. Induction of apoptosis programmed cell death by human leukemic HL-60 cells by inhibition of RNA protein synthesis. J Immunol 1990; 145: 1856-1867.
148. [148] Batisatatou A, Greene LA. Internucleosomal DNA cleavage and neuronal cell survival/death. J Cell Biol 1993; 122: 523-532.
149. [149] Ueda N, Shah SV. Endonuclease-induced DNA damage and cell death in oxydant injury to renal tubular epithelial cells. J Clin Invest 1992; 90: 2593-2597.
150. [150] Deng G, Podack ER. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deragulated expression of the protooncogene bcl-2. Proc Natl Acad Sci USA 1993; 90: 2189-2193.
151. [151] Lewis JG, Adams DO, Fan S. Selective sensibility of macrophages to cytotoxicity by inhibitors of macromolecular synthesis: induction of apoptosis. J Leukoc Biol 1995; 57: 635-642.
152. [152] Vaux DL, Weissman IL. Neither macromolecular synthesis nor myc is required for cell death via the mechanism that can be controlled by bcl-2. Mol Cell Biol 1993; 13: 7000-7005.
153. [153] Canman CE, Gilmer TM, Coutts SB, Kastan MB. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev 1995; 9: 600-611.
154. [154] Koskinen PJ, Alitalo K. Role of c-myc amplification and overexpression in cell growth, differentiation and death. Cancer Biol 193; 4: 3-12.
155. [155] Buttyam R, Zakeri Z, Lockshin R, Wolgemuth D. cascade induction of c-fos, c-myc, and heat shock 70 K transcripts during regression of the rat ventral prostate gland. Mol Endocrinol 1988; 2: 650-657.
156. [156] Evan GI, Wyllie AH. Gilbert CS, Littlewood TD, Land H, Brooks M et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992; 119: 119-128.
157. [157] Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissoonette RP, Green DR. role for c-myc in activation-induced apoptotic cell death in T cell hybridoma. Science 1992; 257: 212-214.
158. [158] Askew DS, Ashmen RA, Simmons BC, Cleveland JL. Constitutive c-myc expression in an IL-3 dependant myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 1991; 6: 1915-1922.
159. [159] Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced c-myc is inhibited by bcl-2. Nature 1992; 359: 552-554.
160. [160] Wood AC, Elvin P, Hickman JA. Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression. Br J Cancer 1995; 71: 937-941.
161. [161] Gibson AW, Cheng T, Johnston RN. Apoptosis induced by c-myc overexpression is dependent on growth conditions. Exp Cell Res 1995; 218: 351-358.
162. [162] Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992; 359: 554-556.
163. [163] Hermeking H, Eick D. Mediation of c-myc-induced apoptosis by p53. Science 1994; 265: 2091-2093.
164. [164] Wagner AJ, Small MB, Hay N. Myc-mediated apoptosis is blocked by ectopic expression of blc-2. Mol Cell Biol 1993; 13: 2432-2440.
165. [165] Oren M. p53: the ultimate tumor suppresor gene?. FASEB J 1992; 6: 3169-3176.
166. [166] Rosenfeld MR, Meneses P, Dalmau J, Drobnjak M, Cordon-Cardo C, Kaplitt MG. Gene transfert of wild-type p53 results in restoration of tumor-suppressor function in a medulloblastoma cell line. Neurology 1995; 45: 1533-1539.
167. [167] Owens GP, Hahn WE, Cohen JJ. Identification of mRNAS associated with programmed cemm death in immature thymocytes. Mol Cell Biol 1991; 11: 4177-4188.
168. [168] Shaw P, Bovey R, Tardy S, Sahli R, Sorda B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992; 89: 4495-4499.
169. [169] Yonish-Rouach E, Resnitsky D, Lotem J, Sachs L, Kimchi A, Oren M. wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352: 345-347.
170. [170] Clarke AR, Gledhill S, Hooper ML, Bird CC, Wyllie AH. p53 dependance of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation. Oncogene 1994; 9: 1767-1773.
171. [171] Chang F, Syrjanen S, Tervahauta A, Syrjanen K. Tumorigenesis associated with the p53 tumour suppressor gene. Br J Cancer 1993; 68: 653-661.
172. [172] Lane DP. Cancer. p53, guardian of the genom. Nature 1992; 358: 15-16.
173. [173] Lane DP. A death in the life of p53. Nature 1993; 362: 786-787.
174. [174] Lu X, Lane DP. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 1993; 75: 765-778.
175. [175] Colombel M, Olsson CA, Ng PY, Buttyan R. Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res 1992; 52: 4313-4319.
176. [176] El-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
177. [177] Harper JW, Adami GR, Wei N, Keyormarsi K, Elledge SJ. The p21 Cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependant kinases. Cell 1993; 75: 805-816.
178. [178] Sheikh MS, Rochefort H, Garcia M. Overexpression of p21WAF/CIPl induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 1995; 11: 1899-1905.
179. [179] Akashi M, Hachiya M, Osawa Y, Spirin K, Suzuki G, Koeffler HP. irradiation induces WAF1 expressio through a p53-independent pathway in KG-1 cells. J Biol Chem 1995; 270: 19181-19187.
180. [180] Shao ZM, Dawson MI, Li XS et al. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 1995; 11: 493-504.
181. [181] Bracey TS, Miller JC, Preece A, Paraskeva. γ-radiation-induced apoptosis in human colorectal adenocarcinoma and carcinoma cell lines can occur in the absence of wild type p53. Oncogene 1995; 10: 2391-2396.
182. [182] Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. Thymocyte apoptosis indiced by p53-dependant and independant pathways. Nature 1993; 362: 849-852.
183. [183] Lowe SW, Schmitt EM, Smitt S, Osborne BA, Jacks T. p53 is required for radiation induced apoptosis in mouse thymocytes. Nature 1993; 362: 847-849.
184. [184] Strasser A, Harris AW, Jacks T, Corry S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independant mechanisms inhibitable by bcl-2. Cell 1994; 79: 329-339.
185. [185] Malcomson RDG, Oren M, Wykkie AH, Harrison DJ. p53-independant death and p53-induced protection against apoptosis in fibroblasts treated with chemotherapeutic drugs. Br J Cancer 1995; 72: 952-957.
186. [186] Wood KA, Youle RJ. The role of free radicals and p53 in neuron apoptosis in vivo. J Neurosci 1995; 15: 5851-5857.
187. [187] Winoto A. Molecular characterization of the Nur77 orphan steroid receptor in apoptosis. Int Arch Allergy Immunol 1994; 105: 344-346.
188. [188] Grassili E, de Prati AC, Monti D et al. Studies of the relationship between cell proliferation and cel death. II; Early gene expression during concavanilin A-induced proliferation or dexamethasone-induced apoptosis of rat thymocytes. Biochem Biophys Res Commun 1992; 188: 1261-1266.
189. [189] Walker PR, Kwast-Welfeld J, Gourdeau H, Leblanc J, Neugebauer W, Sikoska M. Relationship between apoptosis and the cell cycle in lymphocytes: role of protein kinase, tyrosine phosphorylation, and AP1. Exp Cell Res 1993; 207: 142-151.
190. [190] Colotta F, Polentaruutti N, Sironi M, Mantovani A. Expression and involvement of c-fos and c-jun proto-oncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell line. J Biol Chem 1992; 267: 18278-18283.
191. [191] Nagata S, Goldstein P. The Fas death factor. Science 1995; 267: 1449-1456.
192. [192] Suzuki A, Masato E, Yutaka E, Akaio M, Shigekazu N, Yoschihide S, Taisen I. Involvement of Fas in regression of vaginal epithelia after ovariectomy and during estrus cycle. EMBO J 1996; 15: 211-215.
193. [193] Tsujimoto Y, Finger LR, Yunis J, Novell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t14;18 chromosome translocation. Science 1984; 226: 1097-1099.
194. [194] Hockenberry D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
195. [195] Krajewski S, Tanaka S, Takayama S, Shibler MJ, Fenton W, Reed JC. investigation of the subcellular distribution of the bcl-2 oncoprotein : residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 1993; 53: 4701-4714.
196. [196] Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988; 335: 440-442.
197. [197] Allsopp TE, Wyatt S, Paterson HF, Davies AM. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor dependant neurons from apoptosis. Cell 1993; 73: 295-307.
198. [198] Garcia I, Martinou I, Tsujimoto Y, Martinou JC. Prevention of programmed cell death of sympathetic neurons by bcl-2 proto-oncogene. Science 1992; 258: 302-304.
199. [199] Nunez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 1990; 144: 3602-3610.
200. [200] Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67: 879-888.
201. [201] Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. epstein-barr virus-coded BHRF 1 protein, a viral homolog of bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA 1993; 90: 8479-8483.
202. [202] Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogne. Nature 1993; 361: 739-742.
203. [203] Tang C, Willingham MC, Reed JC et al. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre B leukemia cells. Leukemia 1994; 8: 1960-1969.
204. [204] Martinou JC, Dubois Dauphin M, Staple JK et al. Overexpresion of BCL-2 in trangenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 1994; 13: 1017-1030.
205. [205] McDonnel TJ, Deane N, Platt FM et al. Bcl-2 immunoglobuli transgenicmice demonstrate extendded B cell survival and follicular lymphoproliferation. Cell 1989; 57: 79-88.
206. [206] Strasser A, Harris AW, Cory S. Bcl-2 transgene inhibits T cell death and pertubs thymic self-censorship. Cell 1991; 67: 889-899.
207. [207] Keith FJ, Bradbury DA, Zhu YM, Russell NH. Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensibility of AMLblasts to Rra-C. Leukemia 1995; 9: 131-138.
208. [208] Vaux DL, Aguila HL, Weissman IL. Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing. Int Immunol 1992; 4: 821-824.
209. [209] Cuende E, Ales-Martinez JE, Ding L, Gonzalez-Garcia M, Martinez AC, Nunez G. Programmed cell death by bcl-2 dependant and independant mechanisms in B lymphoma cells. EMBO J 1993; 12: 1555-1560.
210. [210] Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, Reed JC. immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of Bcl-2. Am J Pathol 1994; 145: 1323-1336.
211. [211] Oltvai ZN, Millivai CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelrates programmed cell death. Cell 1993; 75: 609-609.
212. [212] Yang E, Zha J, Jockel J, Boise LH, Thompson CB, Korsmeyer SJ. bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285-291.
213. [213] Boise LH, Gonzalez-Garcia M, Postema CE et al. bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597-608.
214. [214] Barinaga M. Cell suicide: by ICE, not Fire. Science 1994; 263: 754-756.
215. [215] Jaatela M, Benedict M, Tawari M, Shayman JA, Dixit VM. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phopholipase A2 in breast carcinoma cells. Oncogene 1995; 10: 2297-22305.
216. [216] Kinoshita T, Yokota T, Arai K, Miyajima A. Regulation of Bcl-2 expresion by oncogenic Ras protein in hematopoietic cells. Oncogene 1995; 10: 2207-2212.
217. [217] Chiou SK, Rao L, White E. Bcl-2 blocks p53-dependant apoptosis. Mol Cell Biol 1994; 14: 2556-2563.
218. [218] Miyashita T, Harigai M, Hanada M, Reed JC. Identification of a p53-negative response element in the bcl-2 gene. Cancer Res 1994; 54: 3131-3135.
219. [219] Hockenberry DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. bcl-2 functions in an antioxydant pathway to prevent apoptosis. Cell 1993; 75: 241-251.
220. [220] Kane DJ, Sarafian TA, Anton R et al. bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993; 262: 1274-1277.
221. [221] Pace D, Morrison L, Bulmer JN. Proliferative activity in endometrial stromal granulocytes throughout menstrual cycle and early pregnancy. J Clin Pathol 1989; 42: 35-39.
222. [222] Kamat B, Isaacson DM. The immunocytochemical distribution of leukocytic subpopulations in human endometrium. Am J Pathol 1987; 127: 66-73.
223. [223] Booker SS, Jayanetti C, Karalak S, Hsiu J-G, Archer DF. The effect of progesterone on the accumulation of leukocytes in the human endometrium. Am J Obstet Gynecol 1994; 171: 139-142.
224. [224] Baltemez GW. The histological studies of the menstruating mucous membrane of thehuman uterus. carnegie Inst Contrib Embryol 1933; 24: 141-186.
225. [225] Hopwood D, Levison DA. Atrophy and apoptosis in the cyclical human endometrium. J Pathol 1975; 119: 159-166.
226. [226] Nakamura T, Sakai T, Hotchi M. Histochemical demonstration of DNA double strand breaks by in situ 3'-tailing reaction in apoptotic endometrium. Biotech Histochem 1995; 70: 33-39.
227. [227] Tabibzadeh S, Kong QF, Satyaswaroop PG, Zupi E, Marconi D, Romanini C, Kapur S. Distinct regional and menstrual cycle dependant distribution of apoptosis in human endometrium. Potential regulatory role of T cells and TNF-α. Endocrinol J 1994; 2: 87-95.
228. [228] Tabibzadeh S, Bakbania A, Liu R, Zupi E, Marconi D, Romanini C. site and menstrual cycle-dependent expression of proteins of the TNF receptor family, and BCL-2 oncoprotein and phase specific production of TNF-α in human endometrium. Human Reprod 1995; 10: 277-286.
229. [229] Gompel A, Sabourin JC, Martin A, Yaneva H, Audouin J, Decroix Y, Poitout P. Bcl-2 expression in normal endometrium during the menstrual cycle. Am J Pathol 1994; 144: 1195-1202.
230. [230] Otsuki Y, Misaki O, Sugimoto O, Ito Y, Tsujimoto Y, Akao Y. Cyclic bcl-2 gene expression in human uterine endometrium during menstrual cycle. Lancet 1994; 344: 28-29.
231. [231] Harris DR, Savill J. Apoptosis and the prostate. Br J Urol 1995; 75: 27-33.
232. [232] Grifith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189-1192.
233. [233] Sandow BA, West NB, Mormon RL, Brenner RM. Hormonal control of apoptosis in hamster uterine luminal epithelium. Am J Anat 1979; 156: 15-36.
234. [234] Brenner RM, Slayden OD. Ostrogen action in the endometrium and oviduct of rhesus monkeys during RU486 treatment. Human Reprod 1994; 9: 82-97.
235. [235] Slayden OD, Hirst JJ, Brenner RM. Estrogen action in the reproductive tract of rhesus monkeys during antiprogestin treatment. J Endocrinol Metab 1993; 132: 1845-1856.
236. [236] Philippeaux M-M, Piguet PF. Expression of tumor necrosis factor-a and its nRNA in the endometrial mucosa during the menstrual cycle. Am J Pathol 1993; 143: 480-486.
237. [237] GU Y, Jow GM, Moulton BC, Lee C, Sensibar JA, Park-Sarge OK, Chen TJ, Gibori G. Apoptosis in decidual tissue regression and reorganization. Endocrinology 1994; 135: 1272-1279.
238. [238] Murdoch WJ. Programmed cell death in preovulatory ovine follicles. Biol Reprod 1995; 53: 8-12.
239. [239] Guthrie HD, Cooper BS, Welch GR, Zakaria AD, Johnson LA. Atresia in follicles grown after ovulation in the pig: measuremt of increased apoptosis in granulosa cells and reduced follicular fluid estradiol-17 beta. Biol Reprod 1995; 52: 920-927.
240. [240] Joly PD, Tisdall DJ, Heath DA, Lun S, McNatty KP. Apoptosis in bovine granulosa cells in relation to steroid synthesis, cyclic adenosine 3', 5'-monophospahte response to follicle-stimulating hormone. Biol Reprod 1994; 51: 934-944.
241. [241] Nicosia N, Nicosia RF, Saunders BO, Muro-Cacho C. Cell prolifération and apoptosis during development and aging of the rabbit corpus luteum. Ann Clin Lab Sci 1995; 25: 143-157.
242. [242] Palumbo A, Yeh J. In situ localization of apopotosis in the rat ovary during follicular atresia. Biol Reprod 1994; 51: 888-895.
243. [243] Zheng J, Redmer DA, Reynolds LP. Evaluation of growth, cell proliferation, and cell death in bovine corporea lutea throughout the estrous cycle. Biol Reprod 1994; 51: 623-632.
244. [244] Hughes FM, Gorospe WC. Biochemical identification of apoptosis programmed cell death in granulosa cells: evidence for a potential mechanism underlying follicular atresia. Endocrinology 1991; 129: 2415-2422.
245. [245] Tilly JL, Kpwalski KI, Johnson AL, Hsueh AJW. Involvement of apoptosis in ovarian follicular atresia and postovulatory regression. Endocrinology 1991; 129: 2799-2801.
246. [246] Zeleznik AJ, Ihrig L, Bassett SG. Developmental expression of CA2+/Mg2+-dependant endonuclease activity in rat granulosa and luteal cells. Endocrinology 1989; 125: 2218-2220.
247. [247] Kenny N, Williams RE, Kelm LB. Spontaneous apoptosis of cells prepared from the non regressing corpus luteum. Biochem Cell Biol 1994; 72: 531-536.
248. [248] Peluso JJ, Papparlardo A. Progesterone and cell-cell adhesion interact to regulate rat granulosa cell apoptosis. Biochem Cell Biol 1994; 72: 547-551.
249. [249] Braw RH, Tsafriri A. Follicles explanted from pentobarbitone treated rats provide a model for atresia. J Reprod Fertil 1980; 59: 259-265.
250. [250] Harman SM, Louvet JP, Ross GT. Interaction of estrogen and gonadotropins on follicular atresia. Endocrinology 1975; 96: 1145-1152.
251. [251] Braw RH, Barami S, Tsafriri A. Effect of hypophysectomy on atresia of rat preovulatory follicles. Biol Reprod 1981; 25: 989-996.
252. [252] Billig H, Furuta I, Hsueh AJW. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 1994; 133: 2204-2212.
253. [253] Adashi EY, Rohan RM. Intraovarian reulation, peptidergic signaling systems. Trends Endocrinol Metabol 1992; 3: 243-248.
254. [254] Monget P, Monniaux D. Role du système IGF dans l' ovaire. Contracept Fertil Sexual 1994; 1994: 556-563.
255. [255] Chun S-Y, Billig H, Tilly JL, Furuta I, Tsafriri A, Hsueh AJW. gonadotrophin suppression of apoptosis in cultured preovulatory follicles: mediatory role of endogenous-like growth factor-1. Endocrinology 1994; 135: 1845-1853.
256. [256] Eisenhauer KM, Chun SY, Billig H, Hsueh AJ. Growth hormone suppression of apoptosis in preovulatory rat follicles and partial neutralization by insulin-like growth inding protein. Biol Reprod 1995; 53: 13-20.
257. [257] Tilly JL, Billig H, Kowamski KI, Hsueh AJW. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian cells and follicles by a tyrosine kinase-dependant mechanism. Mol Endocrinol 1992; 6: 1942-1950.
258. [258] Westergaard LG, Andersen CY. Epidermal growth factor EGF) in human preovulatory follicles. Human Reprod 1989; 4: 257-260.
259. [259] Khan-Dawood FS. Human corpus luteum: immunocytochemical localization of epidermal growth factor. Fertil Steril 1987; 47: 916-919.
260. [260] Kudlow JE, Kobrin MS, Purchio AF, Twardzik DR, Hernandez ER, Asa SL, Adashi EY. Ovarian transforming growth factor alpha gene expression: immunohistochemical localization to the theca-interstitial cells. Endocrinology 1987; 121: 1577-1579.
261. [261] Lobb DK, Kobrin MS, Kudlow JE, Dorrington JH. transforming growth factor-alpha in the adult bovine ovary: identification in growing ovarian follicles. Biol Reprod 1989; 40: 1087-1093.
262. [262] Billig H, Furuka I, Hsueh AJW. Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid frgamentation in granulosa cells. Endocrinology 1994; 134: 245-252.
263. [263] Naor Z, Yavin E. Gonadotropin-releasing hormone stimulates phospholipid labeling in cultured granulosa cells. Endocrinology 1982; 111: 1615-1619.
264. [264] Johnson AL, Tilly JL. Expression of bcl-x protooncogene nRNA in granulosa cells during ovarian follicular developement. Biol Reprod 1994; 50: 90 Abstract.
265. [265] Tilly JL, Tilly KI, Kenton ML, Johnson AL. Expression of member of the bcl-2 gene family in the immature rat ovary: equine chorionic gonadotrophin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-xlong messenger RNA levels. Endocrinology 1995; 136: 232-241.
266. [266] Ratts VS, Flaws JA, Kolp R, Sorenson CM, Tilly JL. Ablation of bcl-2 expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 1995; 136: 6665-3668.
267. [267] Miyashita T, Reed JC. Bcl-2 oncoprotein blocks chemotherapy induced apoptosis in a human leukemia cell line. Blood 1993; 81: 151-157.
268. [268] Pelletier J, Schalling M, Bucler AJ, Rogers A, Haber DA, Housman D. expression of the ilms tumor gene WT1 in the murine urogenital system. Genes Dev 1991; 5: 1345-1356.
269. [269] Sharma PM, Yang X, Bowman M, Roberts V, Sukumar S. Moleular cloning of rat Wilms tumor complementary DNA and a study of messenger RNA expression inthe urogenital system and the brain. Cancer Res 1992; 52: 6407-6412.
270. [270] Maheswaran S, Park S, Bernard A, Morris JF, Rauscher III FJ, Hill DE, Haber DA. Physical and fuctional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 1993; 90: 5100-5104.
271. [271] Chun S-Y, Eisenhauer KM, Kubo M, Hsueh AJW. Interleukin-1β suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology 1995; 136: 3120-3127.
272. [272] Rauscher III FJ. The WT1 Wilms tumor gene product: a developmentally regulated transcription factor as a tumor suppressor. FASB J 1993; 7: 896-903.
273. [273] McConkey DJ, Hartzell P, Nicotera P, Orrenius S. Stimulation of endogenous endonuclease in cells exposed to oxydative stress. Toxicol Lett 1989; 42: 123-130.
274. [274] Rosen DR, Siddique T, Patterson D et al. Mutations in CU/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
275. [275] Wong GHW, Elwell JH, Oberly LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989; 58: 923-931.
276. [276] Flaws JA, Kugu K, Trbovich AM, Desanti A, Tilly KI, Hirshfield AN, Tilly JL. Interleukin-1-β-converting enzyme-related proteases IRPs and mammalian cell death: dissociation of IRP-induced oligonucleosomal endonuclease activity from morphological apoptosis in granulosa cells of the ovarian follicle. Endocrinology 1995; 136: 5042-5053.
277. [277] Guo MW, Mori E, Xu JP, Mori T. Identification of fas antigen associated with apoptotic cell death in murine ovary. Biochem biophys Res Comm 1994; 203: 1438-1448.
278. [278] Quirk S, Cowan RG, Joshi SG, Henrikson KP. FAS antigen-mediated apoptosi in human granulosa/luteal cells. Biol Reprod 1995; 52: 279-287.
279. [279] Suda T, Takahashi T, Goldstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
280. [280] Jo T, Tomiyama T, Ohashi K et al. Apoptosis of cultured mouse luteal cells induced by tumor necrosis factor-a and interferong. Anat Rec 1995; 241: 70-76.
281. [281] Hayakawa M, Ishida N, Takeuchi K, Shibamoto S, Hori T, Oku N, Ito F, Tsujimoto M. Arachnidonic acid selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 1993; 268: 11290-11295.
282. [282] Yamada K, Otabe S, Nada N, Takane N, Nonaka K. Nitric oxide and nitric oxide synthetase m RNA induction in mouse islet cells by interferon-γ plus tumor necrosis factor-a. Biochem Biophys Res Commun 1993; 197: 22-27.